Sentien Biotechnologies (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- August 10, 2015
- Vertical
- Regenerative Medicine
- Funding URL
- View Funding Page
Company Info
- Founders
- Brian Miller
- Company Description
- Sentien is a developer of new blood conditioning therapies designed to restore balance to the immune system of critically ill patients.
- Market
- Critical Care
- Location
- Medford, MA, USA
- Coinvestors
- Boehringer Ingelheim Venture Fund, Portage Biotech